Soltan, M.A.; Alhanshani, A.A.; Shati, A.A.; Alqahtani, Y.A.; Alshaya, D.S.; Alharthi, J.; Altalhi, S.A.; Fayad, E.; Zaki, M.S.A.; Eid, R.A.
Cyclin Dependent Kinase Inhibitor 2A Genetic and Epigenetic Alterations Interfere with Several Immune Components and Predict Poor Clinical Outcome. Biomedicines 2023, 11, 2254.
https://doi.org/10.3390/biomedicines11082254
AMA Style
Soltan MA, Alhanshani AA, Shati AA, Alqahtani YA, Alshaya DS, Alharthi J, Altalhi SA, Fayad E, Zaki MSA, Eid RA.
Cyclin Dependent Kinase Inhibitor 2A Genetic and Epigenetic Alterations Interfere with Several Immune Components and Predict Poor Clinical Outcome. Biomedicines. 2023; 11(8):2254.
https://doi.org/10.3390/biomedicines11082254
Chicago/Turabian Style
Soltan, Mohamed A., Ahmad A. Alhanshani, Ayed A. Shati, Youssef A. Alqahtani, Dalal Sulaiman Alshaya, Jawaher Alharthi, Sarah Awwadh Altalhi, Eman Fayad, Mohamed Samir A. Zaki, and Refaat A. Eid.
2023. "Cyclin Dependent Kinase Inhibitor 2A Genetic and Epigenetic Alterations Interfere with Several Immune Components and Predict Poor Clinical Outcome" Biomedicines 11, no. 8: 2254.
https://doi.org/10.3390/biomedicines11082254
APA Style
Soltan, M. A., Alhanshani, A. A., Shati, A. A., Alqahtani, Y. A., Alshaya, D. S., Alharthi, J., Altalhi, S. A., Fayad, E., Zaki, M. S. A., & Eid, R. A.
(2023). Cyclin Dependent Kinase Inhibitor 2A Genetic and Epigenetic Alterations Interfere with Several Immune Components and Predict Poor Clinical Outcome. Biomedicines, 11(8), 2254.
https://doi.org/10.3390/biomedicines11082254
